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ABSTRACT
Latent Toxoplasma Gondii Infection Moderates the Association Between the
C677T MTHFR Polymorphism and Cognitive Function in U.S. Adults
Andrew Nathan Berrett
Department of Psychology, BYU
Doctor of Philosophy
Sufficient blood concentrations of folate and the products from its metabolism are
necessary for several cellular functions. The C677T MTHFR polymorphism, present in over half
of the U.S. population, reduces the efficiency of folate metabolism and has been linked to the
onset of multiple psychiatric disorders and cognitive decline. The intracellular parasite
Toxoplasma gondii can infect the human brain and is associated with increased prevalence of
psychiatric disorders and cognitive decline. In vitro studies have found that Toxoplasma gondii
may salvage unmetabolized folate from host cells. Since the C677T MTHFR polymorphism and
infection by Toxoplasma gondii both affect folate metabolism or availability, I used data from
the third National Health and Nutrition Examination Survey to test the hypothesis that latent
toxoplasmosis and the C677T MTHFR polymorphism interact to predict worse cognitive
functioning in U.S. adults. I found a statistically significant interaction effect between
Toxoplasma gondii infection and the C677T MTHFR polymorphism in predicting performance
on a test of reaction time. Subjects who were not infected with Toxoplasma gondii experienced
declines in reaction time with the presence of one or two alleles for the C677T MTHFR
polymorphism. However, this association was reversed for subjects who were seropositive for
Toxoplasma gondii. No interaction effects were observed when predicting performance on a test
of processing speed or a test of short term memory. In conclusion, these findings suggest that
the co-occurrence of Toxoplasma gondii infection and the C677T MTHFR polymorphism may
be associated with improved reaction time.
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Latent Toxoplasma Gondii Infection Moderates the Association Between the C677T MTHFR
Polymorphism and Cognitive Function in U.S. Adults
Healthy cognitive functioning is dependent upon several factors including genetics,
nutrition, environmental influences, and others. Often, these endogenous or exogenous factors
interact in ways that either impair or improve cognitive function. One such case involves the
bioavailability and metabolism of folate. A sufficient blood folate concentration is necessary for
healthy neuronal and cognitive function. Genetic mutation of the methylenetetrahydrofolate
reductase (MTHFR) enzyme and infection with the apicomplexan parasite Toxoplasma gondii
(T. gondii) have each been shown to independently interfere with folate metabolism or
availability. The purpose of this study is to determine the neuropsychological impact of an
interaction between the C677T MTHFR polymorphism and T. gondii infection.
The Folate Cycle
Folates are key nutrients utilized by the human body in several biological processes
including (but not limited to) DNA synthesis and repair, various methylation reactions, and the
conversion of homocysteine to methionine. Sufficient dietary folate is also required for healthy
neurologic development and function (Lan, Guhaniyogi, Horn, Xia, & Graham, 2007). Despite
the multiple uses of folates within the body, humans lack the ability to synthesize them de novo.
Thus, folates must be obtained in the diet via naturally folate-rich plants, artificially fortified
foods (via folic acid), or dietary supplements. While plant-derived folates primarily exist in the
already reduced dihydrofolate (DHF) state, folic acid must first be converted to DHF by
dihydrofolate reductase before it can be further metabolized. Ultimately, whether from natural
folates or from synthetic folic acid, DHF is further converted to the more stable tetrahydrofolate
(THF) state by dihydrofolate reductase (Bailey, 1995). In this form, THF enters the one-carbon
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(1-C) folate cycle in which THF accepts or donates methyl groups to or from its N5 and N10
active sites. Methyl groups are utilized in numerous biochemical pathways and are exchanged
between biomolecules to initiate methylation and other biochemical reactions. A variety of
molecules, including THF, act as transporters of these methyl groups. In folate metabolism,
hydroxymethyltransferase transfers methyl groups from two serines to THF to form 5,10methylenetetrahydrofolate (5,10-MTHF). In the 5,10-MTHF state, this form of folate is prepared
to donate its newly acquired methyl groups to other biological processes.
Several coenzymes assist in the reception or donation of methyl groups to or from THF.
One such enzyme is MTHFR, which acts as a catalyst in the irreversible removal of a single
methyl group from the N10 position of 5,10-MTHF to generate 5-methyltetrahydrofolate (5MTHF). In this form, 5-MTHF is unalterably dedicated to the singular role of methyl donation
to homocysteine with vitamin B12 acting as a co-factor (Bailey, 1995). In other words, once
removed, a methyl group cannot be reattached to 5-MTHF to reform 5,10-MTHF.
The transfer of the final methyl group from 5-MTHF to homocysteine is completed in a
two-step process. The methyl group is briefly handed to an awaiting cobalamin (vitamin B12)
forming methylcobalamin (methyl-B12). Methyl-B12 then transfers the methyl group to
homocysteine thereby converting it into methionine. The process of transferring the methyl
group from 5-MTHF to homocysteine is facilitated by the enzyme methionine synthase. In other
words, methionine synthase simultaneously interacts with 5-MTHF, vitamin B12, and
homocysteine to ultimately transfer the methyl group from 5-MTHF to homocysteine and
thereby convert homocysteine to methionine.
In elevated quantities, homocysteine can become neurologically toxic by interacting with
glutamate and glycine binding sites on N-methyl-D-aspartate receptors and promoting the
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accumulation of reactive oxygen species in the brain. As these reactive oxygen species are
severely damaging to cells, apoptotic and necrotic cell death typically follows their accumulation
(Boldyrev, Bryushkova, Mashkina, & Vladychenskaya, 2013). Therefore, the conversion of
homocysteine to methionine is essential for healthy neurologic function. Following methyl
group donation from 5-MTHF to vitamin B12, the resulting THF product is either recycled or
eliminated.
The C677T MTHFR Polymorphism
Ongoing research efforts have been aimed at uncovering the potential physiologic
consequences of various 1-C folate cycle failures. Potential sources of these failures appear to
vary immensely and may include behavioral, environmental, and/or genetic causes. For instance,
limited availability of folate-rich or fortified foods (such as in developing countries) may
increase the risk of folate deficiency. Alternatively, genetic mutation of key folate cycle
enzymes, such as the MTHFR enzyme, can also significantly alter the efficiency of folate
metabolism (Ho, Massey, & King, 2013).
The most common mutation of the MTHFR enzyme is the C677T single nucleotide
polymorphism (Botto & Yang, 2000). Genetic code for the human MTHFR enzyme is found in
the p36.3-36.2 region of chromosome 1 (Goyette et al., 1994). Mutation of this enzyme may
occur when a cytosine in position 677 of the MTHFR gene is replaced with a thymine. This
point mutation results in the generation of the amino acid valine instead of the expected alanine.
The point mutation reduces the thermostability and, subsequently, enzymatic efficiency of the
enzyme in a step-wise manner depending on whether an individual is heterozygous (C/T) or
homozygous (T/T) for the mutation with the T/T genotype being the fully mutated form (Liew &
Gupta, 2015). One report has predicted that MTHFR efficiency may be reduced by upwards of
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40 to 50 percent in T/T homozygous mutants (Rai, 2017). Due to this reduction in MTHFR
efficiency, less 5-MTHF is produced. Reduced availability of 5-MTHF directly influences the
rate at which methionine synthase can convert homocysteine to methionine.
The epidemiology of the C677T MTHFR polymorphism depends on factors such as
ethnicity with the highest prevalence appearing in countries such as Mexico and Italy and lowest
among individuals of African descent (Botto & Yang, 2000; Wilcken et al., 2003). Previous
reports have suggested that approximately 45% of the United States (U.S.) population may be
CC homozygous (non-mutated), 45% C/T heterozygous, and 10% T/T homozygous (Ho et al.,
2013; "RS1801133,").
The consequences of an MTHFR polymorphism appear to be relatively widespread due
to the multiple uses of folate and the products of folate metabolism throughout the body. In fact,
it is estimated that nearly every type of cell in the human body contains a folate transporter of
some type (Mattson & Shea, 2003). However, due to the neurotoxic properties of elevated
homocysteine and the relatively heavy use of folate in the brain, the neurological and
psychological consequences of MTHFR mutation have received added attention over recent
years. For example, a human embryo developing in a folate-depleted environment is at a
significantly greater risk of developing neural tube defects or spontaneously aborting (Liu et al.,
2014). Further, the frequency of autism spectrum disorder and Down syndrome have each been
reported to be higher in children with MTHFR mutations (Boris, Goldblatt, Galanko, & James,
2004; Liu et al., 2011; Pu, Shen, & Wu, 2013; Wu et al., 2013). Beyond associations with
developmental outcomes, the C677T MTHFR polymorphism has also been associated with
increased rates of migraines, depression, Parkinson’s disease, and Alzheimer’s disease in adults
(Azimova et al., 2013; Bousman, Potiriadis, Everall, & Gunn, 2014; Lok et al., 2014; Rai, 2017).
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It is possible that the link between the C677T MTHFR polymorphism and neurological or
psychological outcomes is related to an elevation of homocysteine. Hyperhomocysteinemia due
to an MTHFR polymorphism may result in impaired DNA repair (Kruman et al., 2002), elevated
concentrations of inflammatory mediators (Mansoori et al., 2012), and even an enhanced
production of molecules such as neurofilaments, tau proteins, and beta-amyloid precursor
proteins associated with neurodegenerative diseases (Hasegawa et al., 2012). Ultimately, prior
literature suggests that the presence of at least one copy of the C677T MTHFR polymorphism
may be related to clinically relevant cognitive decline and increased odds of developing a
psychiatric disorder such as depression.
Toxoplasma gondii
The C677T MTHFR polymorphism is not the only means by which folate metabolism
could become compromised. Several other factors, including environmental ones, may also
negatively affect folate metabolism. One such factor may include the intracellular,
apicomplexan parasite Toxoplasma gondii. While the definitive host for T. gondii is any member
of the cat family, epidemiologic studies suggest that approximately 12 to 13 percent of humans
in the United States (Jones, Kruszon-Moran, Rivera, Price, & Wilkins, 2014) and between 20 to
60 percent of people living in developing countries around the world (Pappas, Roussos, &
Falagas, 2009) may be latently infected with the parasite. No one primary route of transmission
has currently been identified. However, congenital transmission, ingestion of improperly cooked
foods, contaminated water, or exposure to the feces of infected cats may all be potential
candidates (Sakikawa et al., 2012). Upon successful invasion of the host, T. gondii typically
locates to and resides in muscle and neural tissue, including the brain. To preserve itself against
the host immune system, the parasite encapsulates itself in a cyst-like structure formed by a
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parasitophorous vacuole membrane (Weiss & Dubey, 2009). Inside the cyst is a densely packed
cluster of T. gondii bradyzoites. In this form, T. gondii is semi-dormant and cellular division is
slow. The tissue cysts containing T. gondii generally persist for the life of the host and maintain
an ongoing, latent infection often termed “latent toxoplasmosis”. Despite the longevity of T.
gondii cysts, recent findings show that a very small percentage may rupture and form new cysts
(Hill, Sreekumar, Jones, & Dubey, 2007), thereby recycling aged cyst structures with new ones.
Though latent toxoplasmosis is not typically associated with severe or observable
symptoms, the infection itself is not necessarily silent. Latent toxoplasmosis has been associated
with several psychological and neurological outcomes. An abundance of literature centers on
associations between T. gondii infection and dopamine-related behaviors or disorders. For
instance, T. gondii infection may be associated with increased odds of developing schizophrenia
(Fabiani, Pinto, Bonuccelli, & Bruschi, 2015; Flegr, 2013; Henriquez, Brett, Alexander, Pratt, &
Roberts, 2009). Such an association is potentially explained by the parasite’s unique ability to
generate significant concentrations of dopamine, a neurotransmitter linked to multiple behaviors
and neurological functions (Martin et al., 2015; Prandovszky et al., 2011). Dopamine-related
behaviors such as risk-taking (Pedersen, Mortensen, Norgaard-Pedersen, & Postolache, 2012),
addiction (Sutterland et al., 2015), and aggression and impulsivity (Cook et al., 2015) have each
been shown to be potentially modified in infected humans or animals. Beyond the potential links
between T. gondii dopamine production and changes in behavior, the parasite may affect the
human brain in additional ways. For example, the general inflammatory burden of infectious
diseases has been associated with cognitive impairments and neurologic health (Elkind et al.,
2010; Gale, Erickson, Berrett, Brown, & Hedges, 2015; Katan et al., 2013).
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Another potential way in which T. gondii may affect both the psychological and
neurological health of human hosts involves a possible association between T. gondii infection
and cellular concentrations of folate and other factors involved in the 1-C folate cycle.
Massimine et al. (2005) demonstrated that T. gondii may be capable of salvaging folate from
infected host cells. If indeed true, it is possible that infected neural cells could suffer from T.
gondii-related folate depletion and subsequent homocysteine elevation resulting in a decline in
cognitive functioning. However, no studies have yet quantified the amount of folate that is
salvaged from infected cells, nor has any research been conducted to determine the extent to
which T. gondii folate salvaging might impair cognitive functioning. To explore the latter
question, I previously conducted a study in which I used data from Center for Disease Control
and Prevention’s (CDC) third National Health and Nutrition Examination Survey (NHANES) to
determine whether infection with T. gondii might interact with concentrations of multiple folate
cycle factors in the prediction of cognitive functioning (Berrett, Gale, Erickson, Brown, &
Hedges, 2017).
The third NHANES includes data for multiple infectious diseases, nutritional
biochemistries, and cognitive functioning for those who were eligible. Cognitive functioning
was assessed via performance on computerized versions of the symbol digit substitution (SDS),
serial digit learning (SDL), and reaction time (RT) tests as described by Krieg et al. (2001). By
predicting performance on three separate tests of cognitive functioning, I could more specifically
identify which components of cognitive functioning might be particularly affected by reductions
in concentrations of folate factors due to T. gondii infection. The SDS assesses processing speed
but also requires intact working memory and attention to perform well. The SDL is generally
considered a measure of learning and attention and requires normal ability in short term memory.
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The RT is a measure of reaction time involving both sensory and cognitive control systems
(Krieg et al., 2001).
Briefly, the results of the study revealed significant interaction effects between T. gondii
infection status and each of the folate factors examined (folate, vitamin B12, and homocysteine)
in the prediction of performance on the SDL. Specifically, subjects who did not have antibodies
specific for T. gondii exposure performed similarly on the SDL no matter the concentrations of
folate, vitamin B-12, or homocysteine. However, for subjects seropositive for T. gondii
infection, SDL performance significantly worsened as folate and vitamin B-12 concentrations
decreased and as homocysteine increased. Since these interaction effects were limited to the
SDL, I could conclude that reduced folate concentrations, potentially due to T. gondii salvaging,
may particularly affect brain regions that are active in learning and attention such as the
hippocampus or pre-frontal cortex.
Interacting Effects of MTHFR Mutation and T. gondii Infection
Since MTHFR mutation and T. gondii infection each affect the 1-C folate cycle, albeit in
unique ways, it is possible that folate metabolism could be affected by an interaction between
both factors. Especially given the relatively large prevalence of both MTHFR mutation and T.
gondii infection, a significant percentage of the population may be heterozygous or homozygous
for the C677T MTHFR polymorphism while also infected with T. gondii. In this case, cellular
concentrations of folate would initially be reduced due to T. gondii folate salvaging. With a
reduced concentration of available folate, enzymes of the 1-C folate cycle such as MTHFR
would be starved of this initial ingredient necessary for product generation. In people void of
any folate-cycle-related genetic mutations, the consequences of depleted MTHFR product could
be enough to affect cognitive function. However, an individual homo- or heterozygous for an
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MTHFR mutation would simultaneously possess MTHFR enzymes that are less efficient in the
processing or conversion of the now reduced concentration of folate factors. Thus, production of
5-MTHF, the primary product of MTHFR, would be substantially hampered. In this case,
infection by T. gondii would reduce the availability of THF to be metabolized by an MTHFR
enzyme that is already less efficient due to genetic mutation. Figure 1 provides a graphical
presentation of this conceptual model. The downward pointing arrows indicate that, depending
on the color of the arrow, T. gondii infection or the C677T MTHFR polymorphism is responsible
for a decrease in concentration or efficiency of that folate cycle component. Upward pointing
arrows indicate elevations in concentrations or enzymatic efficiency.

Figure 1. Conceptual model of the effects of T. gondii infection and the C677T MTHFR
polymorphism on folate metabolism.
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Helicobacter pylori (H. pylori), a bacterium that resides in the gastric epithelium (Hunt &
Tytgat, 2003; Mobley, Mendz & Hazell, 2001) has also been purported to interfere with folate
metabolism (Akcam, Ozdem, Yilmaz, Gultekin, & Artan, 2007; Berrett, Gale, Erickson, Brown,
& Hedges, 2016a; Beydoun, Dore, Canas, Beydoun, & Zonderman, 2015). Though H. pylori is
indeed biologically different from T. gondii in many ways, the downstream effects of infection
on folate availability by either organism may be generally similar. In 2016, I and an
interdepartmental research group designed a study (Berrett, Gale, Erickson, Brown, & Hedges,
2016b) in which we used data from the CDC’s 1999-2000 NHANES data set to test for the
possibility of an interaction between H. pylori seropositivity and total serum 5-MTHF in the
prediction of cognitive function. Though we were unable to utilize genetic data for this study,
the 1999-2000 cycle of the NHANES survey included data for multiple folate cycle factors
including total serum 5-MTHF, vitamin B12, and homocysteine concentrations. Data for serum
5-MTHF concentration was particularly useful as an indirect measure of MTHFR efficiency
because, since MTHFR is the sole producer of 5-MTHF, a reduced concentration of 5-MTHF
suggests a potential reduction in MTHFR efficiency.
In the 2016 study, cognitive function was assessed through the administration of the Digit
Symbol Coding (DSC) task adapted from the WAIS-III (Wechsler, 1997). The availability of
cognitive assessment data varies by NHANES survey cycle and because this was the only
NHANES survey cycle with 5-MTHF data, we were limited to the DSC as the only measure of
cognitive functioning. This cognitive task is generally considered a measure of processing speed
but optimal performance in this task also requires healthy ability in working memory and
attention (Lezak, Howieson, Bigler, & Tranel, 2012). Performance is measured by the number
of correct substitutions performed within a two-minute time limit.
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Ultimately, our analyses revealed a statistically significant interaction effect between 5MTHF concentration and H. pylori infection in the prediction of DSC task performance. For
uninfected subjects, progressively lower concentrations of 5-MTHF were associated with fewer
correct matches on the DSC. This effect was relatively minor but statistically significant.
However, for subjects who were seropositive for H. pylori infection, the slope of this association
significantly increased suggesting that subjects who were infected with H. pylori and who
simultaneously also had less bioavailability of 5-MTHF (at the time of examination) performed
substantially worse on this test of processing speed compared to uninfected subjects (Berrett et
al., 2016b).
The Current Study
The results of the studies discussed above provide initial evidence and rationale for a
potential interaction effect between T. gondii infection and genetic mutation of the MTHFR
enzyme. The first study presented evidence that T. gondii modifies the association between
serum folate concentration and cognitive functioning (Berrett et al., 2017). The study
investigating the interacting effects between H. pylori infection and serum concentrations of 5MTHF, vitamin B-12, and homocysteine in the prediction of cognitive functioning supports the
theory that folate concentration and metabolism could be affected by organisms such as H. pylori
or T. gondii as well as genetic polymorphisms (Berrett et al., 2016b). However, neither of the
above studies directly test for an interaction effect between T. gondii infection and the C677T
MTHFR polymorphism in the prediction of cognitive functioning. Further, 5-MTHFR or folate
concentrations cannot be used to determine MTHFR genotype. Instead, with MTHFR genotype
data, it would be possible to determine whether T. gondii infection interacts with MTHFR
genotype to predict differences in cognitive functioning.
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In fact, the same data sets created by the CDC that were utilized to explore an interaction
between T. gondii and folate concentrations also contain genetic data for MTHFR genotype.
However, access to this data is limited to researchers who submit and receive approval for a
study proposal. Therefore, I submitted such a proposal to the CDC to gain access to this genetic
data and thereby test my hypotheses. I expected that subjects who were hetero- or homozygous
for the MTHFR C677T polymorphism would perform incrementally worse on tests of cognitive
function compared to those without an MTHFR polymorphism. Further, I expected that T.
gondii infection status would interact with MTHFR genotype to predict worse performance on
tests of cognitive functioning. Specifically, I hypothesized that the degree to which the MTHFR
C677T polymorphism might affect cognitive task performance would be conditional upon T.
gondii infection status.
Aims of the Study
The primary aim of the present study was to determine if mutation of the MTHFR gene
and infection by the intracellular parasite T. gondii would interact to impair cognitive function.
The specific aims and corresponding hypotheses of this study included:
1. Confirm the presence of an association between T. gondii infection and cognitive
functioning as measured by the SDS, SDL, and RT tests. Previous reports (Gale et al.,
2015) have indicated that T. gondii infection alone may be sufficient to affect cognitive
function. However, a confirmation of this association would aid in establishing the
rationale for this study.
2. Test for associations between individual folate cycle factors (folate, vitamin B12,
homocysteine) and cognitive performance. At the time of this study, prior literature still
disagrees concerning the magnitude of effect that folate, vitamin B12, and homocysteine
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levels have on cognitive functioning. Again, confirming such associations would further
justify the rationale for this study. However, the absence of significant main effects
between folate, vitamin B12, or homocysteine with cognitive functioning would not limit
the possibility that interactions with T. gondii might be associated with impaired
cognitive function.
3. Test for an association between the C677T MTHFR mutation and performance on the
SDS, SDL, and RT cognitive assessments. Based on prior literature (Cheng et al., 2010;
Schiepers et al., 2011), I hypothesized that subjects who were hetero- or homozygous for
the MTHFR mutation would perform worse on each of the cognitive assessments
compared to non-mutated subjects. Further, I expected this association to follow a doseresponse pattern. In other words, subjects who were heterozygous for the MTHFR
polymorphism would perform worse than subjects who did not possess the polymorphism
while subjects who were T/T homozygous for the MTHFR polymorphism would perform
worse than either C/C homozygotes or C/T heterozygotes with the biggest contrast being
between T/T homozygotes and C/C homozygotes.
4. Test for an interaction effect between MTHFR genotype and T. gondii infection status in
the prediction of SDS, SDL, and RT test performance. Based on previous findings, I
expected to observe an interacting effect between MTHFR genotype and T. gondii
infection status and that this interaction would significantly relate to SDS, SDL, and RT
test performance. Specifically, I hypothesized that, in uninfected subjects, MTHFR
genotype (C/C, C/T, T/T) would be associated with step-wise reductions in performance
on each cognitive measure. However, I expected that this effect would be substantially
magnified in subjects who were seropositive for T. gondii.
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5. If a statistically significant interaction effect was observed between T. gondii infection
and MTHFR genotype, I would perform a follow-up analysis to further illuminate
potential mechanisms. Specifically, I intended to test if homocysteine concentration
mediates the relationship between the MTHFR genotype and T. gondii interaction in the
prediction of performance on the SDS, SDL, and RT tests. I hypothesized that such a
mediation effect would be revealed and that the MTHFR and T. gondii interaction would
lead to increased concentrations of homocysteine that would subsequently relate to worse
performance on each cognitive assessment.
Materials and Methods
Study Sample
Approximately 34,000 participants were recruited for the third National Health and
Nutrition Examination Survey conducted between 1988 to 1994. The NHANES III was divided
into two phases. Phase 1 spanned the years of 1988 to 1991 while phase 2 was from 1991 to
1994. While much of the data was collected for the entirety of the survey, some was only
collected for a single phase. Further, not all participants were eligible for or chose to participate
in all components of the survey. T. gondii infection status was assessed in all subjects aged 12
years and above for both phases of the NHANES III. MTHFR genotype was acquired for all
subjects aged 12 years and above who were surveyed in phase 2. Total folate and vitamin B12
concentrations were acquired for all eligible participants aged 12 years and above.
Homocysteine concentration was assessed in phase 2 subjects aged 12 years and above. A subsample of subjects aged 20 to 59 years old were administered the SDS, SDL, and RT cognitive
assessments. Thus, the age of the participants in the sample ranged from 20 to 59 years.
Subjects with missing data on any of the above-mentioned measures or covariates were not

Toxoplasma gondii, MTHFR, and Cognition

15

included in my analyses. Due to the restrictions imposed by the remote access system used to
access the necessary data sets, multiple imputation or other methods used to address missing data
were not possible. Ultimately, a total of 1,537 subjects were included in all analyses. Finally, all
data retrieved from the NHANES data sets is cross-sectional by nature. Therefore, any statistical
associations exposed within these NHANES data sets must be considered with this context in
mind.
Toxoplasma gondii
CDC lab technicians tested for the presence of T. gondii antibodies via indirect enzyme
immunoassay. The process requires combining participant serum with T. gondii-specific
antigens and peroxidase labelled anti-human IgG. The addition of a peroxidase substrate and
chromogen substrate serum initiates a color reaction. The resulting color change is proportional
to the concentration of T. gondii antibody in the participant’s serum and can be interpreted and
quantified via spectrophotometer. According to the recommendation of NHANES
documentation, a value of less than 7.00 IU/mL was considered negative for infection while
values at or above 7.00 IU/mL were considered positive for infection (Gunter, Lewis, &
Koncikowski, 1996). Following this convention, I coded all positive results as 1 and all negative
results as 0.
MTHFR Genotype
MTHFR genotyping was performed by CDC technicians. DNA samples were collected
and isolated from 10 mL aliquots of whole blood and normalized to concentrations of
approximately 50 ng/μL ("National Health and Nutrition Examination Survey Biospecimen
Program: NHANES III (1988–1994) and NHANES 1999–2014," 2015). I coded subjects who
were homozygous for the non-mutated C/C MTHFR genotype as 0 and subjects who were
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heterozygous (C/T) or homozygous (T/T) for the C677T MTHFR polymorphism as 1 or 2
respectively. Further, to test for more generalized differences between subjects with or without a
C677T MTHFR mutation, I created a separate variable in which subjects who were C/C
homozygous were coded as 0 and subjects who were either hetero- or homozygous for the
mutation were coded as 1.
Folate Cycle Factors
Serum folate (ng/mL) and vitamin B12 (pg/mL) concentrations were previously
determined by CDC lab technicians using a Quantaphase II folate/vitamin B12 radioassay kit
provided by Bio-Rad Laboratories (Bio-Rad Laboratories, 1993). Following preparation, labeled
and unlabeled folate and vitamin B12 compete for binding sites. Unbound folate and vitamin B12
is discarded while bound substrate collects in pellet form. Radioactivity from the pellets is
measured and compared to a standard curve to determine the concentration of folate and vitamin
B12 in the participant’s blood. To address a right data skew, folate and vitamin B12
concentrations were logarithmically transformed prior to implementation in any statistical
models.
Total homocysteine concentration (μmol/L) was determined by CDC lab technicians
using reverse-phase high-performance liquid chromatography and fluorescence detection. The
degree of fluorescence is compared to a standard curve to determine the concentration of
homocysteine in the sample. As with folate and vitamin B12, homocysteine concentration was
logarithmically transformed to account for a right skew.
Cognitive Function
A random half-sample of survey participants between the ages of 20 to 59 years old were
administered computerized versions of the Symbol Digit Substitution (SDS), Serial Digit
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Learning (SDL), and Reaction Time (RT) tests. Each of these assessments are components of
the Neurobehavioral Evaluations System 2 that was specifically designed for use in
epidemiological studies (Krieg et al., 2001). The SDS is considered a measure of processing
speed but also requires intact memory and attention (Lezak et al., 2012). The SDS is a timed test
requiring participants to match symbols with their corresponding numbers as outlined by a key
placed at the top of the form. Performance on the test is assessed by computing the mean of the
two lowest latencies between matched pairs. Since a lower average latency indicates better or
faster performance, a lower score on the SDS indicates better cognitive functioning.
The SDL is a measure of learning and recall requiring participants to memorize and recall
a series of eight digits over eight trials. For each trial, a score of 0 is given when all eight digits
are successfully recalled. A score of 1 is given when two-thirds of the digits are correctly
recalled, and a score of 2 is given when less than two-thirds of the digits are correctly recalled.
Therefore, a higher score indicates worse performance.
The RT is a test of reaction time requiring participants to press a designated button every
time a box-shaped stimulus appears on a computer screen. Each participant completes 10
practice trials and 40 test trials and the average time recorded (in milliseconds) from the 40 test
trials is used as the final score. Again, since the RT is a time-based task, a lower score (or faster
response) indicates better performance. Participants with physical limitations such as blindness
or those who could not successfully complete an initial practice phase were excluded from
cognitive testing. Additionally, data from participants who stopped a test before the allotted time
were not reported in the NHANES.
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Covariates
I included several covariates in my analyses to control for potential confounding.
Categorical covariates were sex and race-ethnicity. The race-ethnicity variable included
categories for non-Hispanic whites, non-Hispanic blacks, Mexican Americans, and “other”
ethnicities as suggested by NHANES documentation (National Center for Health Statistics,
2011). Continuous covariates were education, poverty-to-income ratio (PIR), and age.
Education was recorded as total years of completed education. PIR is defined as the ratio
between household income and the federally established poverty level at the time of the survey.
Values above 1 are above the poverty threshold whereas values below 1 are in poverty. Age was
measured in years.
Statistical Analysis
Use of the limited access data sets provided by the CDC requires performing statistical
and data processing operations through a remote-access interface called the ANDRE system.
This system utilizes Statistical Analysis Software (SAS) version 9.4 to execute all tasks and
requires researchers to submit prepared SAS code via File Transfer Protocol (FTP). Following
submission, the ANDRE system processes the submitted SAS code and returns all output via email in a text file. I performed all analyses using SAS’s survey-specific commands that allow
for the inclusion of sampling weights to adjust parameter estimates to be representative of the
U.S. civilian non-institutionalized population. Traditionally, in analyzing NHANES data, the use
of provided strata and cluster variables are sufficient for adjusting standard-error estimates to
account for the complex-sampling design of the NHANES data sets. However, due to the
restricted sample included in this study, it was likely that some strata would be limited to a single
cluster. Therefore, as an alternative, I utilized the 52 replicate weights included with the
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NHANES III data to implement Fay’s method of balanced repeated replication (Rao & Shao,
1999) to account for the survey design.
I used linear regression (proc surveyreg) to independently estimate performance on the
SDS, SDL, and RT cognitive assessments from T. gondii seropositivity and each of the folate
cycle factors (folate, vitamin B12, and homocysteine) with included covariates. Next, I used
linear regression to test for significant differences in SDS, SDL, and RT performance between
each of the C677T MTHFR genotypes. To replicate previous findings (Berrett et al., 2017), I
then used linear regression to test for interaction effects between T. gondii infection and each of
the folate factors (folate, vitamin B12, and homocysteine) as separate models in the prediction of
SDS, SDL, and RT performance. Finally, I used linear regression to test for potential interaction
effects between T. gondii infection status and MTHFR C677T genotype in predicting
performance on the SDS, SDL, and RT cognitive assessments. Each analysis included sex, raceethnicity, education, PIR and age as controlling covariates.
Results
Of the 1,537 subjects included in my analyses, 19% were seropositive for a latent T.
gondii infection. Nearly 38% of the total study sample possessed a single C677T MTHFR
polymorphism while 10% were homozygous for the C677T polymorphism. Most subjects were
non-Hispanic White (78%). The sample was balanced between men and women. On average,
subjects were 37 years old, they had achieved 13 years of education, and were earning an income
about 3 times greater than the federal poverty level. These summary statistics and others are
presented in Table 1.

Toxoplasma gondii, MTHFR, and Cognition

20

Table 1
Unweighted Summary Statistics of the Study Sample
Mean/Proportion

SE

Symbol Digit Substitution Score

2.59

.04

Serial Digit Learning Score

4.08

.16

236.01

1.38

.19

.02

C/C

.52

.02

C/T

.38

.01

T/T

.10

.01

7.24

.24

Vitamin B-12 (mg/dL)

491.57

12.50

Homocysteine (mg/dL)

9.52

.26

Non-Hispanic White

.78

.02

Non-Hispanic Black

.09

.01

Mexican American

.06

.01

Other

.07

.02

.50

.01

Age (years)

37.26

.72

Education (years)

13.03

.13

Poverty-to-income Ratio

3.35

.12

Reaction Time (ms)
Toxoplasma Gondii Seropositivity
MTHFR Genotype

Folate (mg/dL)

Race-ethnicity

Male

Note. Means were calculated for continuous variables and proportions for
categorical and binary variables.
N = 1,537
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Ordinary least squares regression analysis with T. gondii seropositivity predicting
performance on each of the three cognitive measures revealed a statistically significant effect
between T. gondii seropositivity and performance on the SDL (β = .76 [95% CI: -.17, -1.36], p =
.01). On average, subjects who were seropositive for T. gondii achieved an SDL score .76 points
higher than seronegative subjects indicating worse performance (Table 2). T. gondii
seropositivity did not predict performance on the SDS or RT.
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Table 2
Toxoplasma Gondii Seropositivity Predicting Performance on Three Measures of Cognitive Functioning in U.S. Adults
Symbol Digit Substitution

Serial Digit Learning

Reaction Time

β

95% CI

β

95% CI

β

95% CI

.08

[-.02, .19]

.76*

[-.17, -1.36]

4.62

[-2.72, 11.97]

Non-Hispanic Black

.28***

[.19, .36]

1.97***

[1.36, 2.58]

5.23

[-.70, 11.15]

Mexican American

.26***

[.14, .39]

2.42***

[1.73, 3.11]

.171

[-7.02, 7.36]

Other

.24**

[.07, .42]

1.88**

[.55, 3.21]

-4.95

[-14.39, 4.48]

Male

-.17***

[-.25, -.10]

.21

[-.14, .57]

4.75

[-1.45, 10.96]

Age

.03***

[.02, .03]

.08***

[.05, .10]

.37**

[.10, .64]

Education

-.10***

[-.12, -.08]

-.49***

[-.63, -.35]

-2.67***

[-3.70, -1.64]

Poverty-to-income Ratio

-.03***

[-.05, -.02]

-.20**

[-.32, -.08]

-3.52***

[-4.79, -2.26]

Constant

3.10***

[2.77, 3.43]

8.37***

[6.37, 10.38]

270.06***

[252.82, 287.30]

Toxoplasma Gondii
Race-ethnicity
Non-Hispanic White (ref)

Note. CI = confidence interval, ref = reference category
N = 1,537
* p < .05 ** p < .01 *** p < .001
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No statistically significant associations were observed for folate, vitamin B12, or
homocysteine concentrations in predicting performance on any of the three cognitive
assessments while controlling for race-ethnicity, sex, age, education, and PIR (Tables 3-5).
Similarly, the C677T MTHFR polymorphism, whether defined by genotype (CC, CT, TT) or the
presence or absence of a T-allele (CC, CT or TT), did not predict performance on the SDS, SDL,
or RT assessments (Tables 6-7). As stated previously, statistically significant associations
between these factors and the cognitive assessments were not required to establish the case for
moderation by another factor. Therefore, tests of moderation by T. gondii were still warranted.
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Table 3
Folate Concentration Predicting Performance on Three Measures of Cognitive Functioning in U.S. Adults
Symbol Digit Substitution

Serial Digit Learning

Reaction Time

β

95% CI

β

95% CI

β

95% CI

-.00

[-.06, .06]

-.17

[-.61, .27]

1.98

[-2.99, 6.95]

Non-Hispanic Black

.28***

[.19, .36]

1.95***

[1.32, 2.58]

5.71

[-.09, 11.51]

Mexican American

.26***

[.14, .39]

2.41***

[1.70, 3.12]

.24

[-6.87, 7.35]

Other

.25**

[.07, .43]

1.92**

[.58, 3.26]

-4.64

[-13.79, 4.52]

Male

-.17***

[-.25, -.10]

.23

[-.16, .62]

4.48

[-1.96, 10.92]

Age

.03***

[.02, .03]

.09***

[.06, .11]

.39**

[.11, .68]

Education

-.11***

[-.12, -.09]

-.50***

[-.63, -.36]

-2.77***

[-3.77, 1.78]

Poverty-to-income Ratio

-.03***

[-.05, -.02]

-.21**

[-.33, -.09]

-3.61***

[-4.93, -2.30]

Constant

3.02***

[2.71, 3.34]

7.82***

[5.62, 10.02]

263.61***

[245.91, 281.31]

Folate
Race-ethnicity
Non-Hispanic White (ref)

Note. CI = confidence interval, ref = reference category
N = 1,537
* p < .05 ** p < .01 *** p < .001
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Table 4
Homocysteine Concentration Predicting Performance on Three Measures of Cognitive Functioning in U.S. Adults
Symbol Digit Substitution

Serial Digit Learning

Reaction Time

β

95% CI

β

95% CI

β

95% CI

-.04

[-.14, .05]

-.40

[-1.11, .32]

-3.65

[-9.79, 2.48]

Non-Hispanic Black

.28***

[.19, .37]

1.98***

[1.35, 2.61]

5.27

[-.69, 11.23]

Mexican American

.26***

[.13, .39]

2.38***

[1.69, 3.06]

-.22

[-7.46, 7.02]

Other

.25**

[.07, .43]

1.98**

[.64, 3.33]

-4.18

[-13.38, 5.02]

Male

-.18***

[-.27, -.10]

.11

[-.31, .52]

3.80

[-2.48, 10.07]

Age

.03***

[.02, .03]

.09***

[.06, .11]

.43**

[.14, .73]

Education

-.11***

[-.13, -.09]

-.51***

[-.64, -.37]

-2.75***

[-3.78, -1.73]

Poverty-to-income Ratio

-.03***

[-.05, -.02]

-.22**

[-.34, -.10]

-3.64***

[-4.97, -2.31]

Constant

3.11***

[2.77, 3.46]

8.52***

[6.01, 11.03]

273.63***

[250.77, 296.45]

Homocysteine
Race-ethnicity
Non-Hispanic White (ref)

Note. CI = confidence interval, ref = reference category
N = 1,537
* p < .05 ** p < .01 *** p < .001
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Table 5
Vitamin B12 Concentration Predicting Performance on Three Measures of Cognitive Functioning in U.S. Adults
Symbol Digit Substitution

Serial Digit Learning

Reaction Time

β

95% CI

β

95% CI

β

95% CI

.05

[-.01, .10]

-.01

[-.49, .48]

-2.43

[-8.46, 3.60]

Non-Hispanic Black

.27***

[.18, .36]

1.99***

[1.34, 2.63]

5.78

[-.45, 12.00]

Mexican American

.26***

[.13, .38]

2.42***

[1.70, 3.14]

.42

[-6.86, 7.70]

Other

.25**

[.07, .43]

1.93**

[.57, 3.28]

-4.94

[-14.12, 4.31]

Male

-.17***

[-.25, -.10]

.21

[-.14, .56]

4.69

[-1.49, 10.87]

Age

.03***

[.02, .03]

.08***

[.06, .11]

.40**

[.12, .69]

Education

-.10***

[-.12, -.08]

-.50***

[-.64, -.37]

-2.73**

[-3.75, -1.72]

Poverty-to-income Ratio

-.03***

[-.05, -.02]

-.21***

[-.33, -.10]

-3.53***

[-4.80, -2.27]

Constant

2.74***

[2.24, 3.24]

7.68***

[4.49, 10.86]

280.70***

[244.33, 317.07]

Vitamin B12
Race-ethnicity
Non-Hispanic White (ref)

Note. CI = confidence interval, ref = reference category
N = 1,537
* p < .05 ** p < .01 *** p < .001
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Table 6
C677T MTHFR Genotype Predicting Performance on Three Measures of Cognitive Functioning in U.S. Adults
Symbol Digit Substitution

Serial Digit Learning

Reaction Time

β

95% CI

β

95% CI

β

95% CI

C/T

.01

[-.06, .08]

.19

[-.24, .61]

-.34

[-6.44, 5.75]

T/T

.03

[-.08, .15]

.53

[-.14, 1.20]

2.91

[-6.80, 12.61]

Non-Hispanic Black

.29***

[.20, .37]

2.09***

[1.50, 2.67]

5.58

[-.60, 11.75]

Mexican American

.26***

[.13, .39]

2.36***

[1.65, 3.07]

.05

[-7.19, 7.2]

Other

.25**

[.07, .43]

1.95**

[.64, 3.27]

-4.66

[-14.00, 4.69]

Male

-.17***

[-.25, -.10]

.18

[-.16, .53]

4.60

[-1.69, 10.89]

Age

.03***

[.02, .03]

.08***

[.06, .11]

.41**

[.12, .71]

Education

-.11***

[-.13, -.09]

-.50***

[-.64. -.37]

-2.71***

[-3.74, -1.68]

Poverty-to-income Ratio

-.03***

[-.05, -.02]

-.21**

[-.32, -.09]

-3.56***

[-4.89, -2.23]

Constant

3.01***

[2.71, 3.31]

7.53***

[5.44, 9.63]

265.20***

[248.32, 282.09]

MTHFR Genotype
C/C (ref)

Race-ethnicity
Non-Hispanic White (ref)

Note. CI = confidence interval, ref = reference category
N = 1,537
* p < .05 ** p < .01 *** p < .001
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Table 7
C677T MTHFR T-allele Predicting Performance on Three Measures of Cognitive Functioning in U.S. Adults
Symbol Digit Substitution

Serial Digit Learning

Reaction Time

Β

95% CI

β

95% CI

β

95% CI

-.02

[-.08, .05]

-.26

[-.66, .14]

-.34

[-6.69, 6.01]

Non-Hispanic Black

.28***

[.20, .37]

2.07***

[1.49, 2.65]

5.42

[-.77, 11.61]

Mexican American

.26***

[.13, .39]

2.36***

[1.65, 3.08]

.08

[-7.16, 7.31]

Other

.25**

[.07, .43]

1.96**

[.63, 3.28]

-4.64

[-13.94, 4.67]

Male

-.17***

[-.25, -.10]

.19

[-.16, .55]

4.72

[-1.44, 10.88]

Age

.03***

[.02, .03]

.08***

[.06, .11]

.41**

[.11, .70]

Education

-.11***

[-.13, -.09]

-.50***

[-.64, -.37]

-2.72***

[-3.76, -1.69]

Poverty-to-income Ratio

-.03***

[-.05, -.02]

-.21**

[-.32, -.09]

-3.57***

[-4.91, -2.23]

Constant

3.03***

[2.72, 3.34]

7.83***

[5.64, 10.02]

265.89***

[248.12, 283.65]

C677T MTHFR T-allele
C/C (ref)
C/T or T/T
Race-ethnicity
Non-Hispanic White (ref)

Note. CI = confidence interval, ref = reference category
N = 1,537
* p < .05 ** p < .01 *** p < .001
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Statistically significant interactions were observed between T. gondii seropositivity and
folate concentration in predicting performance on the SDL (β = -1.28 [-2.13, -.43], p = .001) and
RT assessments (β = 10.20 [.09, 20.32], p = .05) directly replicating the results I obtained in a
previous study (Berrett et al., 2017) (Table 8). Subjects who were seronegative for T. gondii
varied little in their performance on the SDL as folate concentrations increased or decreased. In
contrast, subjects who were T. gondii seropositive performed worse on the SDL as folate
concentration decreased. An interaction effect was also observed between T. gondii
seropositivity and homocysteine concentration in predicting SDL performance (β = 3.06 [1.81,
4.31], p <.001) (Table 9). The interaction between T. gondii seropositivity and homocysteine
concentration was like that of T. gondii and folate except that for T. gondii seropositive subjects,
SDL performance worsened as homocysteine increased. No interaction effects were observed
between T. gondii infection and vitamin B12 concentration in predicting any of the cognitive
measures (Table 10).
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Table 8
Interaction Effects Between T. gondii Seropositivity and Folate Concentration Predicting Performance on Three Measures of
Cognitive Functioning in U.S. Adults
Symbol Digit Substitution

Serial Digit Learning

Reaction Time

β

95% CI

β

95% CI

β

95% CI

Toxoplasma Gondii

.22

[-.02, .47]

2.97***

[1.34, 4.60]

-12.97

[-28.53, 2.59]

Folate Concentration

.01

[-.04, .07]

.11

[-.36, .58]

-.06

[-4.72, 4.61]

T. gondii x Folate Interaction

-.08

[-.22, .06]

-1.28**

[-2.13, -.43]

10.20*

[.09, 20.32]

Non-Hispanic Black

.28***

[.19, .36]

1.92***

[1.30, 2.53]

5.82*

[.01, 11.62]

Mexican American

.27***

[.14, .39]

2.45***

[1.76, 3.14]

-.00

[-7.14, 7.13]

Other

.24**

[.07, .41]

1.85**

[.53, 3.16]

-4.68

[-13.91, 4.56]

Male

-.17***

[-.25, -.10]

.21

[-.17, .60]

4.63

[-1.79, 11.06]

Age

.03***

[.02, .03]

.08***

[.06, .11]

.33*

[.07, .58]

Education

-.10***

[-.12, -.08]

-.48***

[-.62, -.35]

-2.77***

[-3.76, -1.77]

Poverty-to-income Ratio

-.03***

[-.05, -.02]

-.20**

[-.32, -.08]

-3.54***

[-4.84, -2.23]

Constant

2.98***

[2.67, 3.29]

7.13***

[5.02, 9.24]

268.44***

[252.04, 284.84]

Race-ethnicity
Non-Hispanic White (ref)

Note. T. gondii = Toxoplasma gondii, CI = confidence interval, ref = reference category
N = 1,537
* p < .05 ** p < .01 *** p < .001
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Table 9
Interaction Effects Between T. gondii Seropositivity and Homocysteine Concentration Predicting Performance on Three Measures of
Cognitive Functioning in U.S. Adults
Symbol Digit Substitution

Serial Digit Learning

Reaction Time

β

95% CI

β

95% CI

β

95% CI

Toxoplasma Gondii

-.31

[-1.29, .66]

-5.91***

[-8.67, -3.15]

-14.85

[-47.78, 18.07]

Homocysteine Concentration

-.07

[-.16, .02]

-.85*

[-1.53, -.18]

-4.96

[-12.20, 2.28]

T. gondii x Homocysteine Interaction

.18

[-.27, .63]

3.06***

[1.81, 4.31]

8.92

[-7.76, 25.60]

Non-Hispanic Black

.28***

[.19, .37]

2.01***

[1.40, 2.62]

5.30

[-.67, 11.28]

Mexican American

.26***

[.13, .39]

2.45***

[1.76, 3.13]

.00

[-7.18, 7.19]

Other

.25**

[.08, .42]

1.97**

[.62, 3.29]

-4.36

[-13.78, 5.06]

Male

-.19***

[-.27, -.10]

.08

[-.34, .51]

3.74

[-2.59, 10.07]

Age

.03***

[.02, .03]

.09***

[.06, .11]

.41**

[.13, .69]

Education

-.10***

[-.12, -.08]

-.49***

[-.63, -.36]

-2.69***

[-3.73, -1.65]

Poverty-to-income Ratio

-.03***

[-.05, -.02]

-.21***

[-.33, -.10]

-3.60***

[-4.91, -2.29]

Constant

3.15***

[2.84, 3.47]

9.23***

[6.73, 11.74]

275.56***

[252.59, 298.54]

Race-ethnicity
Non-Hispanic White (ref)

Note. T. gondii = Toxoplasma gondii, CI = confidence interval, ref = reference category
N = 1,537
* p < .05 ** p < .01 *** p < .001
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Table 10
Interaction Effects Between T. gondii Seropositivity and Vitamin B12 Concentration Predicting Performance on Three Measures of
Cognitive Functioning in U.S. Adults
Symbol Digit Substitution

Serial Digit Learning

Reaction Time

β

95% CI

β

95% CI

β

95% CI

Toxoplasma Gondii

1.30*

[.01, 2.60]

7.60*

[.00, 15.20]

9.84

[-117.49, 137.17]

Vitamin B12 Concentration

.08**

[.03, .14]

.19

[-.34, .71]

-2.43

[-8.42, 3.57]

-.20

[-.41, .01]

-1.12

[-2.36, .12]

-.84

[-21.39, 19.71]

Non-Hispanic Black

.27***

[.18, .36]

1.98***

[1.35, 2.61]

5.72

[-.49, 11.93]

Mexican American

.26***

[.14, .39]

2.46***

[1.75, 3.16]

.49

[-6.76, 7.74]

Other

.25**

[.07, .42]

1.88**

[.55, 3.20]

-5.24

[-14.70, 4.21]

Male

-.17***

[-.25, -.10]

.21

[-.13, .56]

4.70

[-1.46, 10.86]

Age

.03***

[.02, .03]

.08***

[.05, .10]

.36*

[.09, .64]

Education

-.10***

[-.12, -.08]

-.49***

[-.63, -.35]

-2.68***

[-3.73, -1.63]

Poverty-to-income Ratio

-.03***

[-.05, -.02]

-.20**

[-.32, -.08]

-3.48***

[-4.71, -2.24]

Constant

2.50***

[2.06, 2.94]

6.37***

[3.03, 9.71]

280.41***

[241.32, 319.51]

T. gondii x Vitamin B12 Interaction
Race-ethnicity
Non-Hispanic White (ref)

Note. T. gondii = Toxoplasma gondii, CI = confidence interval, ref = reference category
N = 1,537
* p < .05 ** p < .01 *** p < .001
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While no interaction effects were observed between T. gondii and C677T MTHFR
genotype in predicting performance on the SDS or SDL, a statistically significant interaction
effect was observed in predicting RT performance (β = -19.85 [-35.92, -3.78], p = .017) (Table
11; Figure 2). For subjects who were T. gondii seronegative, heterozygous and homozygous
mutations of the MTHFR gene were associated with worse reaction time with the homozygous
mutation being associated with the most substantial increases in reaction time. In contrast, in
subjects seropositive for T. gondii, heterozygous and homozygous C677T mutations of the
MTHFR gene were associated with faster reaction time with the homozygous mutation being
associated with the fastest reaction time. In a more generalized format, the same effect was
observed if genotype for the C677T MTHFR polymorphism was operationalized as the presence
(CT or TT) or absence (CC) of a T-allele (β = 15.14 [1.71, 28.57], p = .03) (Table 12; Figure 3).
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Table 11
Interaction Effects Between T. gondii Seropositivity and C677T MTHFR Genotype Predicting Performance on Three Measures
of Cognitive Functioning in U.S. Adults
Symbol Digit Substitution

Serial Digit Learning

Reaction Time

β

95% CI

β

95% CI

β

95% CI

.13

[-.00, .27]

.88

[-.07, 1.82]

11.97*

[1.65, 22.29]

C/T

.03

[-.03, .09]

.20

[-.27, .68]

2.26

[-3.81, 8.33]

T/T

.05

[-.05, .15]

.70

[-.10, 1.51]

7.03

[-4.24, 18.30]

T. gondii x C/T

-.10

[.32, .12]

-.04

[-1.73, 1.65]

-13.84

[-29.08, 1.39]

T. gondii x T/T

-.10

[-.47, .27]

-.93

[-2.87, 1.01]

-19.85*

[-35.92, -3.78]

Non-Hispanic Black

.28***

[.20, .36]

2.07***

[1.51, 2.63]

5.18

[-1.09, 11.44]

Mexican American

.26***

[.13, .39]

2.36***

[1.67, 3.05]

.03

[-7.17, 7.23]

Other

.24**

[.07, .42]

1.94**

[.64, 3.24]

-4.53

[-14.00, 4.93]

Male

-.18***

[-.25, -.11]

.19

[-.13, .51]

4.16

[-2.34, 10.66]

Age

.03***

[.02, .03]

.08***

[.05, .10]

.38**

[.11, .66]

Toxoplasma Gondii
C677T MTHFR Genotype
C/C (ref)

T. gondii x MTHFR Genotype Int.
T. gondii x C/C (ref)

Race-ethnicity
Non-Hispanic White (ref)
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Table 11 Continued
Symbol Digit Substitution

Serial Digit Learning

Reaction Time

β

95% CI

β

95% CI

β

95% CI

Education

-.10***

[-.12, -.08]

-.50***

[-.64, -.36]

-2.71***

[-3.72, -1.70]

Poverty-to-income Ratio

-.03***

[-.05, -.02]

-.19**

[-.31, -.08]

-3.51***

[-4.84, -2.18]

Constant

3.00***

[2.70, 3.31]

7.48***

[5.39, 9.57]

264.09***

[247.58, 280.60]

Note. T. gondii = Toxoplasma gondii, CI = confidence interval, ref = reference category, int. = interaction
N = 1,537
* p < .05 ** p < .01 *** p < .001
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Figure 2. Interaction effect between C677T MTHFR genotype and T. gondii seropositivity predicting reaction time.
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Table 12
Interaction Effects Between T. gondii Seropositivity and C677T MTHFR T-allele Predicting Performance on Three Measures of
Cognitive Functioning in U.S. Adults
Symbol Digit Substitution

Serial Digit Learning

Reaction Time

β

95% CI

β

95% CI

β

95% CI

.03

[-.13, .19]

.64

[-.30, 1.57]

-3.11

[-12.59, 6.36]

-.03

[-.09, .02]

-.30

[-.77, .17]

-3.21

[-9.62, 3.20]

.10

[-.11, .31]

.25

[-1.22, 1.71]

15.14*

[1.71, 28.57]

Non-Hispanic Black

.28***

[.20, .36]

2.05***

[1.48, 2.61]

4.97

[-1.29, 11.22]

Mexican American

.26***

[.13, .39]

2.37***

[1.67, 3.07]

.08

[-7.14, 7.30]

Other

.24**

[.07, .42]

1.91**

[.60, 3.23]

-4.72

[-13.99, 4.56]

Male

-.18***

[-.25, -.10]

.19

[-.15, .53]

4.21

[-2.05, 10.47]

Age

.03***

[.02, .03]

.08***

[.05, .10]

.37**

[.10, .65]

Toxoplasma Gondii
C677T MTHFR T-allele
C/C (ref)
C/T or T/T
T. gondii x MTHFR Genotype Int.
T. gondii x C/C (ref)
T. gondii x C/T or T/T
Race-ethnicity
Non-Hispanic White (ref)
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Table 12 Continued
Symbol Digit Substitution

Serial Digit Learning

Reaction Time

β

95% CI

β

95% CI

β

95% CI

Education

-.10***

[-.12, -.08]

-.50***

[-.64, -.36]

-2.70***

[-3.71, -1.69]

Poverty-to-income Ratio

-.03***

[-.05, -.02]

-.20**

[-.32, -.08]

-3.55***

[-4.86, -2.24]

Constant

3.04***

[2.72, 3.35]

7.82***

[5.58, 10.07]

267.73***

[250.32, 285.13]

Note. T. gondii = Toxoplasma gondii, CI = confidence interval, ref = reference category, int. = interaction
N = 1,537
* p < .05 ** p < .01 *** p < .001
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Figure 3. Interaction effect between C677T MTHFR T-allele and T. gondii seropositivity predicting reaction time.
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Discussion
In this study of 1,537 young to middle-aged U.S. adults, I used data from the third
NHANES to test the hypothesis that seropositivity for T. gondii moderates the association
between the C677T MTHFR polymorphism and impairments in cognitive functioning. No
significant interaction effects were observed between T. gondii infection and the C677T MTHFR
polymorphism in predicting performance on the SDS or SDL. However, a statistically
significant interaction effect was observed between T. gondii seropositivity and the C677T
MTHFR polymorphism in predicting reaction time. Specifically, while subjects who were
seronegative for T. gondii infection had slower reaction times with increasing degrees of
MTHFR mutation (i.e. one or two T-alleles), subjects who were seropositive for T. gondii
infection achieved better reaction times with increasing degrees of MTHFR mutation. While this
finding was not in line with my original hypotheses, it may reveal a unique association between
T. gondii infection and the C677T MTHFR polymorphism in the context of mental health and
cognitive performance.
Over 19 percent of the total sample was seropositive for a latent T. gondii infection. This
frequency is in line with other reports (Jones et al., 2001). Importantly, this estimate reflects the
proportion of U.S. individuals who were seropositive for T. gondii infection between the years of
1988 and 1994. Data from more recent epidemiological surveys report a lower T. gondii
seroprevalence with estimates ranging between 10 to 12 percent (Jones et al., 2014). The
reduction in T. gondii seroprevalence over the past three decades may be due to improved
awareness of the parasite among pet owners and pet care professionals such as veterinarians.
Improved awareness could lead to changes in pet care in the home, veterinary screening
practices, and new options for eliminating the parasite from carrier organisms (Dabritz &
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Conrad, 2010). Despite the encouraging changes in T. gondii seroprevalence, the CDC still
considers T. gondii to be one of the top five neglected parasitic infections in the U.S (Parise,
Hotez, & Slutsker, 2014). Further, while more recent estimates of T. gondii seroprevalence
appear to be lower in the U.S. in comparison to past decades (Jones et al., 2014), seroprevalence
in developing nations seems to have changed little and remains much higher than the
seroprevalence observed in the U.S. (Tilahun et al., 2016; Wilking, Thamm, Stark, Aebischer, &
Seeber, 2016). Therefore, T. gondii infection remains both a nation and world-wide concern.
Approximately 48 percent of the sample was either heterozygous (38 percent) or
homozygous (10 percent) for the C677T MTHFR polymorphism, a frequency that matches
previous national estimates (Liew & Gupta, 2015; Peng, Labelle, Rainey, & Tsongalis, 2001).
In testing for associations between latent toxoplasmosis and performance on the three
tests of cognitive functioning, individuals seropositive for T. gondii performed significantly
worse on the SDL, a test of short-term memory, than their uninfected counterparts. This finding
matches that of a previous report using the same data (Gale et al., 2015) and reinforces other
literature suggesting that infectious pathogens such as T. gondii might be associated with
increased risk for cognitive decline in adults (Flegr, 2015; Mendy, Vieira, Albatineh, & Gasana,
2015; Pearce, Kruszon-Moran, & Jones, 2014). However, research is still lacking to describe the
potential mechanisms by which T. gondii might affect cognitive functioning. Further, limited
research has explored the various ways in which T. gondii infection might modify the association
between other factors, such as folate metabolism, and cognitive functioning.
In a previous report (Berrett et al., 2017), I used data from the NHANES III to test for
interaction effects between infection with T. gondii and blood concentrations of folate,
homocysteine, and vitamin B12 in the prediction of scores on the SDS, SDL, and RT cognitive
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assessments. In that report, T. gondii seropositivity significantly moderated the association
between folate and homocysteine concentrations in predicting performance on the SDL and RT
cognitive assessments. The same analyses were performed in this study and, expectedly, the
same results were obtained. As discussed previously (Berrett et al., 2017), the interaction effects
that predict performance on the SDL may suggest that the relationship between folate
concentration and cognitive functioning might differ based on the presence or absence of latent
toxoplasmosis. Theoretically, this could be due to direct salvaging of intracellular folate by T.
gondii. Salvaging of intracellular folate by T. gondii may lead to elevated levels of
homocysteine because less product from folate metabolism (i.e. 5-MTHF) would be available to
convert homocysteine into methionine. In this regard, one could suppose that, in the presence of
another factor that might also impair folate metabolism, cognitive functioning might be further
impaired. Such is the underlying theory of the current report in that the C677T MTHFR
polymorphism is indeed another factor, genetic by nature, that could also negatively impact
folate metabolism. Therefore, I hypothesized that the impairments in cognitive functioning
observed in the previous report (Berrett et al., 2017), as well as the current report, particularly for
the SDS or SDL, would be more substantial in subjects who were affected by both T. gondii
infection and the C677T MTHFR genetic polymorphism.
Since no interaction effect was observed between T. gondii infection and folate
concentration in predicting performance on the SDS, associations between T. gondii and
processing speed or other components of cognitive functioning employed in the SDS task must
operate through a mechanism other than folate salvaging. A common theory is that infectious
pathogens such as T. gondii might trigger an inflammatory response that is damaging to both the
pathogen and the host. In the case of T. gondii, which is resistant to inflammatory defenses
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(Laliberte & Carruthers, 2008), damage to the host could continue indefinitely for the life of the
parasite. Since latent toxoplasmosis often persists for the life of the host, collateral inflammatory
damage could eventually result in clinically relevant changes in host health, particularly if initial
infection occurred earlier in life. Unfortunately, the NHANES datasets did not include data for
typical measures of the cerebral immune response including pro-inflammatory cytokines (e.g.
interleukin-6 and tumor necrosis factor) or anti-inflammatory cytokines (e.g. interleukin-4 and
interleukin-10) (Woodcock & Morganti-Kossmann, 2013). Therefore, given the absence of such
data, I was unable to determine whether inflammation plays any mediating or moderating role in
the prediction of an association between T. gondii infection and performance on the SDS.
Contrary to my proposed hypotheses, no significant interaction effects were observed
between T. gondii infection and hetero- or homozygosity for the C677T MTHFR polymorphism
in predicting performance on the SDL or SDS cognitive assessments. These null results could
potentially be explained by several factors. First, the sample used for these analyses were
between the ages of 20 and 59 years. It is possible that interaction effects between T. gondii
infection and the C677T MTHFR polymorphism might exist in an older population in which
cognitive decline is more likely. Relatedly, cognitive decline from either T. gondii or the C677T
MTHFR polymorphism is not likely an instantaneous process and instead may increase over
multiple years or decades. Therefore, by analyzing individuals between the ages of 20 to 59
years, observing significant interaction effects may be less likely because the sample consists of
generally healthy (both physically and cognitively) individuals who are less likely to be
experiencing cognitive decline usually associated with older age. Alternatively, the cognitive
tests used in the NHANES III might not have been sensitive to the effects of the C677T MTHFR
polymorphism on cognitive functioning. For example, the polymorphism has been associated
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with alterations in attention and executive control, both of which being components of general
cognitive functioning but not explicitly assessed by any of the three cognitive assessments
available in the NHANES III (Krull et al., 2008; Pathansali et al., 2006). Therefore, detection of
statistically significant interaction effects between T. gondii infection and mutation of the C677T
MTHFR polymorphism may have been possible had more cognitive testing data been available,
particularly for components of cognitive functioning more likely to be affected by the C677T
MTHFR polymorphism.
Furthermore, because an interaction effect was observed between T. gondii and folate but
not between T. gondii and the C677T MTHFR mutation in predicting performance on the SDL, it
is possible that the interplay between T. gondii and folate might occur before folate is modified
or metabolized by the MTHFR enzyme. Indeed, in the report that provides the first evidence of
folate salvaging by T. gondii, Massimine et al. (2005) describes a plasma membrane transporter
system in T. gondii that is highly specific for the THF form of folate. Therefore, T. gondii may
not salvage the metabolized forms of folate such as 5-MTHF. If so, T. gondii salvaging could
lead to a depletion of available THF, but not necessarily a depletion of 5-MTHF. Since most
available THF is almost immediately converted to 5-MTHF (Bailey, 1995; Obeid, Kirsch,
Kasoha, Eckert, & Herrmann, 2011), reduced availability of THF may not significantly drain the
available pool of 5-MTHF. Instead, the limited stores of unmetabolized THF may be partially
depleted to maintain the rate of THF delivery to the MTHFR enzyme.
Interestingly, the conversion of THF to 5,10-MTHF (the folate form converted by
MTHFR to 5-MTHF) leads to the generation of glycine, a molecule necessary for the generation
of purines. Purines are, in turn, required for the synthesis of nucleic acids and proteins and are
heavily utilized in multiple biochemical reactions requiring energy input. In neurons, purines
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such as adenosine are key to functions such as neural plasticity and recovery (Dias, Rombo,
Ribeiro, Henley, & Sebastiao, 2013; Kurpius, Nolley, & Dailey, 2007). Therefore, if T. gondii
were to infect neural cells in highly plastic brain regions such as the hippocampus or prefrontal
cortex, specific THF salvaging could lead to the reduced production of purines (or other
molecules) necessary for neural plasticity. Further, evidence suggests that T. gondii may also
directly salvage purines (adenine, guanine, xanthine, and hypoxanthine) from host cells
(Chaudhary et al., 2004; Coppens, 2014; Hyde, 2007). Therefore, T. gondii may also deplete
available stores of purines directly through host cell salvaging and indirectly through THF
salvaging. An ongoing, latent infection could perpetuate this scenario for the duration of the
hosts life thus potentially increasing the risk for memory loss or other general cognitive deficits
later in life by reducing the materials necessary for synaptic plasticity and other energy requiring
functions in neural cells.
Also, the experimentation performed by Massimine et al. (2005) was conducted in vitro
and does not provide any description or characterization of folate salvaging by T. gondii within
an infected host, particularly in respect to the different stages of infection. For example, it is
possible that T. gondii might salvage more folate during the initial acute phase of infection to
improve survivability and less after it has transitioned into an encapsulated latent infection. The
opposite could also be true. Due to the cross-sectional nature of the NHANES data, I was unable
to assess blood folate concentrations at different time points across the infection process and no
other studies have yet explored this theory. Further, in vitro experimentation does not allow for
the consideration of potential host adaptation. Perhaps, after the parasite has entered a latent
phase, host cells may compensate for the constant drain of THF (or possibly other folate forms)
by storing more THF or sourcing it from other parts of the body. Further research (preferably in
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vivo and in humans) is required to determine whether host cells might adapt to T. gondii folate
salvaging after long-term infection.
Finally, despite the significant interaction effect observed between T. gondii and folate in
predicting performance on the SDL, it is also possible that the observed effect is capturing a less
direct relationship between T. gondii and cellular folate concentration, suggesting that T. gondii
may not actually influence cellular levels of folate to a clinically significant degree. Instead, the
observed interaction between T. gondii and folate could be a case of overlapping but very
separate effects. For example, reduced folate concentrations may be associated with worse
performance on the SDL due to elevated levels of homocysteine, which can eventually be
neurotoxic. On the other hand, T. gondii infection could also trigger an immune response that
results in persistent neuroinflammation. In this scenario, T. gondii and folate both influence
performance on the SDL, but the point of interaction is not in folate levels, but in inflammation.
However, as stated previously, the NHANES datasets do not contain sufficient data for markers
of inflammation to test this possibility.
While no interaction effects were observed between latent toxoplasmosis and the C677T
MTHFR polymorphism in predicting performance on the SDS or SDL cognitive assessments, an
interaction effect was observed in predicting performance on the RTT. The statistically
significant effect predicted improved performance on the RTT for subjects seropositive for T.
gondii infection. Specifically, for subjects who were T. gondii seronegative, reaction time was
adversely affected in an incremental manner by the presence of one or two T-alleles for the
C677T MTHFR polymorphism. T. gondii seronegative subjects achieved slower reaction times
if they had one or two T-alleles as opposed to seronegative subjects with no C677T MTHFR
polymorphism (no T-alleles). In contrast, subjects who were seropositive for T. gondii infection
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experienced the opposite effect. For those subjects, the presence of one or two T-alleles for the
C677T MTHFR polymorphism was associated with incremental improvements in reaction time.
Therefore, T. gondii seropositive subjects achieved faster reaction times if they had at least one
T-allele for the C677T MTHFR polymorphism when compared to seropositive subjects with no
T-alleles. Only the difference between homozygous C/C and homozygous T/T subjects was
statistically significant.
While this study is the first to report a specific interaction effect between latent
toxoplasmosis and the C677T MTHFR polymorphism in predicting reaction time, other reports
may indirectly support the validity of the finding. For example, in two previous reports using the
same NHANES III data, I observed similar interaction effects between an infectious pathogen
and blood folate concentration in predicting faster reaction time. Most recently, I found that
latent toxoplasmosis moderated the relationship between blood folate concentration and reaction
time (Berrett et al., 2017). In that study, subjects who were seropositive for T. gondii infection
appeared to achieve faster reaction times as blood folate concentrations decreased. Similarly, in
a study exploring the cognitive consequences of infection with H. pylori, while not statistically
significant, I observed a similar relationship between the bacterium and changes in reaction time
performance (Berrett et al., 2016b). Specifically, subjects who were seropositive for the cagA
variant of H. pylori appeared to achieve faster reaction times as blood folate levels decreased.
The agreement between these studies suggests that an underlying connection may exist between
infectious pathogens (such as T. gondii and H. pylori) and reaction time performance. Indeed,
while T. gondii and H. pylori differ in many ways, including their gross physiology, location of
infection within the human body, and the way they interact with the host, both may influence the
availability of THF, the first component of the folate cycle. T. gondii may salvage THF from
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infected cells (Massimine et al., 2005) while H. pylori may reduce THF absorption via gastric
inflammation (Berrett et al., 2016b; Kountouras, Gavalas, Boziki, & Zavos, 2007). Therefore, an
important link between infectious pathogens such as T. gondii and H. pylori and reaction may be
the availability of THF or a similar factor related to the metabolism of THF.
Despite the potential theoretical support from studies I previously conducted, each utilize
the same data from the NHANES III dataset. Additional findings from studies that do not utilize
the NHANES III data may further characterize the association between the T. gondii/MTHFR
interaction and improvements in reaction time. For example, using a modified stop-change
paradigm, Stock, Heintschel von Heinegg, Kohling, and Beste (2014) observed that subjects who
were seropositive for T. gondii infection exhibited better action control than seronegative
subjects. However, like the current study, no direct association was observed between T. gondii
infection and reaction time suggesting that other moderating or mediating factors should be
considered. Further, a report by Sugden et al. (2016) also found no significant differences in
reaction time between T. gondii seropositive and seronegative subjects. The study sample
recruited by Sugden et al. (2016) included individuals in New Zealand who were born between
April 1972 and March 1973. While that report did not find any significant differences in
reaction time between the two groups, folate concentrations or C677T MTHFR genotype were
not considered. It is possible that in the case of low folate concentration or a homozygous
C677T MTHFR polymorphism, the effects of T. gondii infection could be more pronounced or
more potent. In addition to the findings of Sugden et al. (2016), a different report observed a
disadvantage in processing speed for schizophrenic and control subjects infected with T. gondii
(Pearce et al., 2013). However, blood folate concentrations and C677T MTHFR genotype were
again not considered.
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While some disagreement exists regarding the presence and directionality of an
association between latent toxoplasmosis and reaction time, potential mechanisms of such an
association can still be posited. One possible theory involves the parasite’s unique ability to
utilize proteins and other biological compounds available in the host cell to generate large
concentrations of dopamine. While the purpose of generating the neurotransmitter is still
unclear, the consequences seem to be more apparent thanks to ongoing research on the topic.
Possibly the most intuitive and direct evidence that the dopamine generated by T. gondii affects
human hosts is the numerous reports of associations between T. gondii seropositivity and
diagnosis with schizophrenia (Hinze-Selch et al., 2007; Yolken, Dickerson, & Fuller Torrey,
2009). Other behavioral or cognitive differences that have been observed between T. gondii
seropositive and seronegative individuals (de Barros et al., 2017; Suvisaari, Torniainen-Holm,
Lindgren, Harkanen, & Yolken, 2017) may be due to the location of the infection in the brain.
However, most reports suggest that, once in the brain, T. gondii is relatively impartial when
choosing a permanent infection site (McConkey, Martin, Bristow, & Webster, 2013). Therefore,
depending on the distribution of T. gondii cysts throughout the brain, infected individuals will
likely experience different consequences of infection.
Optimal reaction time requires contributions from, among others, brain regions involved
in executive control, attention, and fine and gross motor control (Chudasama et al., 2003;
Prinzmetal, McCool, & Park, 2005). Such brain regions are modulated by multiple
neurotransmitters, including dopamine, and function differently when concentrations of the
neurotransmitter are altered, whether naturally or artificially. For example, evidence suggest that
depletion of dopamine is associated with changes in executive control, attention, and movement
(Luo & Levin, 2017; Ramdani et al., 2015; van Dyck et al., 2008) which may lead to
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impairments in reaction time (Grant, Kuepper, Wielpuetz, & Hennig, 2014). Therefore, factors
that remedy or compensate for dopamine depletion may improve reaction time. For example, in
a study by Pezze, Dalley, and Robbins (2007), investigators administered D1 and D2 dopamine
receptor agonists to mice and observed significant improvements in attentional control and
perseverative responding in a reaction time task when both dopamine receptors were agonized at
optimal levels. In contrast, D1 and D2 receptor blockade led to overall impairments in task
performance. In another study, investigators observed a significantly higher prevalence of T.
gondii infection in individuals diagnosed with Parkinson’s disease compared to controls
suggesting that T. gondii may modify the outcomes of the disease (Miman, Kusbeci, Aktepe, &
Cetinkaya, 2010). If T. gondii invades neural systems involved in attentional control, motor
control, or other systems related to reaction time performance, it is possible that the dopamine
generated by the parasite may act as a dopamine receptor agonist and thereby modify behavior.
However, such a hypothesis is difficult to test due to the seemingly random localization of T.
gondii cysts in the brain. Also, it is difficult to determine whether T. gondii would affect one or
many neural systems that might modify reaction time performance.
Though the dopamine generated by T. gondii might lead to improved reaction time, this
association may be tempered by the more global effects of infection. Following successful
invasion, the parasite ultimately invades and inhabits neurons, thereby triggering both local and
systemic inflammatory processes. If necessary, some infected cells will attempt to trigger
apoptosis, or programmed cell death, to protect against spreading infection. However, the
parasite is equipped with the ability to negate that cellular command (Laliberte & Carruthers,
2008). Built to survive indefinitely within a hosts’ neural cells, the immune system is unable to
eliminate the parasite and the immune system resorts to maintained systemic inflammation to
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limit the effects of the foreign invader. While important for immune function, protracted
inflammation has been linked to general cognitive decline. For example, the build-up of amyloid
plaques triggers an ongoing inflammatory response and is likely responsible for much of the
cognitive decline observed in Alzheimer’s disease (Heneka et al., 2015; Tai et al., 2015).
Therefore, the neuroinflammation associated with T. gondii infection may lead to impairments in
various cognitive functions such as attention or executive control which would in turn impair
reaction time. Ultimately, the association between T. gondii infection and reaction time seems to
be relatively complex given that the parasite may affect reaction time both positively via
dopamine generation and also negatively via neuroinflammation.
Though no association was observed in this study between the C677T MTHFR
polymorphism and performance on the RTT, some indirect links may still exist. For example,
one direct consequence of MTHFR mutation is increased blood levels of homocysteine.
Elevated homocysteine, or hyperhomocysteinemia, is neurotoxic to the brain and may affect
neurotransmitter levels (Bhatia & Singh, 2015; Selhub, Bagley, Miller, & Rosenberg, 2000). In
fact, some theories point to hyperhomocysteinemia as an important risk factor for psychiatric
diseases such as depression and schizophrenia, both of which are significantly associated with
concentrations of certain neurotransmitters including dopamine (Bhatia & Singh, 2015; Selhub et
al., 2000). The C677T MTHFR polymorphism reduces the efficiency of the MTHFR enzyme in
converting 5,10-MTHF to 5-MTHF, a substrate required for the conversion of homocysteine to
methionine. The absence of sufficient 5-MTHF to convert homocysteine leads to a potential
decrease in available methionine. The converted methionine product is necessary for several
methyl-donating reactions including those involved in the generation of neurotransmitter
precursor molecules used to make dopamine, norepinephrine, serotonin and other
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neurotransmitters (Selhub, 2000; Almeida 2005; Alpert, 2000). Thus, the C677T MTHFR
polymorphism may ultimately lead to reduced production of several neurotransmitters and
thereby increase risk for psychiatric or neurologic disease. Indeed, hetero- and homozygosity for
the C677T MTHFR polymorphism has been linked to, among others, depression, Parkinson’s
disease, and schizophrenia (Liew & Gupta, 2015; Nishi et al., 2014; Wu, Ding, Sun, Yang, &
Sun, 2013). The C677T MTHFR polymorphism has also been associated with impaired
attention and changes in executive control (Krull et al., 2008; Pathansali et al., 2006).
Presumably, these associations could be mediated or moderated by reductions in
neurotransmitter generation due to the less efficient conversion of homocysteine to methionine.
However, additional research is required to confirm such a mechanism.
It is possible that both T. gondii infection and the C677T MTHFR polymorphism may be
related to reaction time via modulation of neurotransmitter levels. While T. gondii might
improve reaction time by generating surplus dopamine, the C677T MTHFR polymorphism may
impair reaction time by limiting the efficiency of folate metabolism which in turn reduces the
production of neurotransmitter precursor molecules. This convergence may explain the
interaction effect observed in this study. Specifically, in T. gondii seronegative individuals,
being hetero- or homozygous for the C677T MTHFR polymorphism was associated with worse
reaction time. This pattern is in line with the theory that the C677T MTHFR polymorphism
might impair reaction time due to depleted dopamine or other neurotransmitters. However, in
individuals seropositive for latent toxoplasmosis, reaction time was better for individuals who
were hetero- and homozygous for the C677T MTHFR polymorphism. Therefore, it appears that
the surplus dopamine produced by T. gondii may counteract the effects of the C677T MTHFR
polymorphism. In other words, latent toxoplasmosis appears to be a compensatory factor, at a
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significantly significant level, against the effects of C677T MTHFR polymorphism on reaction
time.
Importantly, the results of this study do not suggest that the co-presence of T. gondii
infection and C677T MTHFR mutation promote a more favorable situation over someone who is
T. gondii seronegative and/or does not possess the C677T MTHFR polymorphism. Instead, T.
gondii may be at least partially responsible for the recovery of reaction time performance in the
event that an individual possesses one or two copies of the C677T MTHFR polymorphism.
However, given the cross-sectional nature of the NHANES data, it is impossible to determine the
exact mechanistic process by which T. gondii infection might influence the relationship between
the C677T MTHFR polymorphism and reaction time. The possibility that and infectious
pathogen such as T. gondii might provide any benefit to the infected host is rarely considered.
Generally, infection by an organism such as T. gondii is assumed to be accompanied with
unfavorable outcomes. Indeed, multiple such consequences or outcomes of T. gondii infection
have already been identified (Fabiani et al., 2015; Fekadu, Shibre, & Cleare, 2010). However,
the results of this study add to the limited literature suggesting potential benefits, so to speak, of
T. gondii infection (Stock, 2014). In fact, the possibility that T. gondii infection might reverse
the deleterious effects of another factor on cognitive functioning, such as the C677T MTHFR
polymorphism, may provide some evidence that latent toxoplasmosis might also moderate the
outcomes of other factors that also affect cognitive functioning. For example, Parkinson’s
disease is characterized by the degeneration of dopaminergic circuits in the substantia nigra. Of
the few studies that have explored possible associations between T. gondii infection and
Parkinson’s disease, none have yet determined whether the dopamine produced by T. gondii
might affect the outcomes of the disease (Celik et al., 2010; Miman et al., 2010). While the
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results of the current study certainly do not translate to Parkinson’s disease, they do offer
motivation for additional research to explore the potential avenues by which the dopamine
generated by T. gondii might affect the human brain, if at all.
Another consideration in interpreting the interaction effects between T. gondii infection
and the C677T MTHFR polymorphism is the possibility that T. gondii may be responsible for
causing other transcriptional abnormalities that might alter how the C677T MTHFR
polymorphism might after cognitive functioning. Investigations into how T. gondii might affect
a human host post-infection has revealed several transcriptional changes in infected and
neighboring cells due to the release of micro-RNA by T. gondii (Sacar, Bagci, & Allmer, 2014;
Zeiner, Norman, Thomson, Hammond, & Boothroyd, 2010). The genetic influences by T. gondii
are likely intended to increase the survivability and longevity of the parasite (Thirugnanam,
Rout, & Gnanasekar, 2013; Xiao et al., 2014). However, it is possible that the genetic influences
of T. gondii might have secondary effects. At this point, no studies have yet explored potential
intersections between the genetic or physiological influences of T. gondii and the C677T
MTHFR polymorphism.
Several factors require consideration when interpreting the results of this study. The
cross-sectional nature of the NHANES data limits the ability to determine important factors such
as the age or time in which an individual was infected with T. gondii. It is possible that the
results of the current study could vary based on the duration or frequency in which an individual
has been exposed to or infected with T. gondii. It was also not possible, given the available data
in the NHANES III, to determine the location of T. gondii cysts within each seropositive subject.
Generally, such information is only available post-mortem. Further, the NHANES data set did
not include data for all variables or measures necessary to determine the specific mechanisms
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involved in the observed findings. For example, subjects were not tested for dopamine or other
neurotransmitter levels as such tests were not within the objectives or scope of the NHANES.
Also, in the NHANES III, only subjects between the ages of 20 and 59 were assessed for
cognitive functioning. It is possible that the observed effects could differ in other populations,
such as the elderly, where cognitive decline is more common and a greater risk. While the
NHANES III did contain three different assessments of cognitive functioning, performance on
those assessments should only be considered as a snapshot of each subject’s cognitive health or
ability. Additional assessments and/or neuroimaging are typically required to make more
conclusive determinations about an individual’s cognitive health. Finally, while I attempted to
control for several potential confounding factors, it is unlikely that I accounted for all factors that
might affect the outcomes of this study. For example, other factors besides the C677T MTHFR
polymorphism likely affect folate metabolism and/or alter blood concentrations of folate cycle
molecules such as homocysteine.
Despite the potential limitations listed above, this study is also supported by several
strengths. The NHANES data sets provide an invaluable opportunity to conduct research using a
nationally representative sample. After limiting my analyses to subjects with data for the
necessary study variables, each analysis was based on over 1,500 subjects who represent
multiple race-ethnicities, socioeconomic groups, and other demographic factors. Therefore, the
results of this study can be generalized to the U.S. young to middle-aged adult population. The
large sample size also improves statistical power and reduces the likelihood that the observed
effects are due to statistical error. Further, by including sociodemographic factors such as PIR,
education, race-ethnicity, and others as controlling covariates in each statistical model, I could be
more confident that the observed effects were due to the variables of interest and not due to
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extraneous factors. Finally, because I used data for three different measures of cognitive
functioning as estimates of cognitive ability, I could improve the specificity of my findings by
identifying effects that may have been specific to certain components of cognitive functioning.
In conclusion, I found that infection by the apicomplexan parasite T. gondii may
moderate the association between the C677T MTHFR polymorphism and cognitive functioning.
Contrary to my original hypotheses, T. gondii infection did not moderate the relationship
between the C677T MTHFR polymorphism and performance on the SDS or SDL. Instead, I
observed a previously undescribed relationship between T. gondii infection and the C677T
MTHFR polymorphism in which infection by T. gondii appeared to reverse or compensate for
the deleterious effects of the C677T MTHFR polymorphism on reaction time. However, given
the cross-sectional nature of the data, describing the exact mechanism by with T. gondii and the
C677T MTHFR polymorphism may interact within the infected host cell was not possible. Thus,
the implications of these findings are complex and further research is necessary to better explore
the context and mechanisms involved in the observed associations. The importance of these
findings is emphasized by the relatively high prevalence of both T. gondii infection and mutation
of the MTHFR enzyme in U.S. adults (Jones et al., 2014; "RS1801133,"). In fact, given the rates
observed in the sample included in this study, it is possible that between five and ten percent of
the U.S. population may be simultaneously affected by T. gondii and the C677T MTHFR
polymorphism. Therefore, additional research is recommended to determine the extent of the
interaction effects between T. gondii infection and mutation of the C677T MTHFR
polymorphism on cognitive function.
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